InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Richard Scott Struthers, President & CEO, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 15 open-market SEC Form 4 transactions: 0 purchases worth $0 and 15 sales worth $20.0M, reported from Sep 7, 21 to Mar 16, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 26 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 13.2K | $37.77 | $490K |
| Sep 26, 25 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 4.0K | $45.00 | $180K |
| Mar 19, 25 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 16.5K | $34.83 | $563K |
| Dec 2, 24 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 10.0K | $57.57 | $576K |
| May 8, 24 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 107.4K | $49.40 | $5.3M |
| Apr 4, 24 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 41.0K | $49.17 | $2.0M |
| Nov 3, 23 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 199.1K | $30.56 | $6.1M |
| Nov 2, 23 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 918 | $29.95 | $27K |
| Jul 13, 23 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 14.2K | $20.35 | $288K |
| Jul 12, 23 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 11.5K | $20.17 | $231K |
| Jul 11, 23 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 24.4K | $20.14 | $491K |
| Jun 16, 23 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 50.0K | $20.81 | $1.0M |
| Apr 13, 22 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 69.2K | $27.53 | $1.9M |
| Apr 5, 22 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 21.4K | $25.34 | $541K |
| Sep 7, 21 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 10.0K | $25.00 | $250K |